What ATMA CENA does

ATMA CENA (legal entity: AtmaCena Inc.) is a Calgary-headquartered, Edmonton-anchored Canadian specialty healthcare company that operates a platform-plus-network model for psychedelic-assisted mental healthcare. It runs two corporate clinics (Edmonton and Calgary) that deliver General Therapy, Psychedelic-Assisted Therapy (PAT) using ketamine, psilocybin, and MDMA via Health Canada's Special Access Programme (SAP), and Repetitive Transcranial Magnetic Stimulation (rTMS), targeting treatment-resistant depression, anxiety, PTSD, addiction, chronic pain, end-of-life distress, and tinnitus. The company is fully licensed under Alberta's Psychedelic Drug Treatment Services (PDTS) framework and holds CPSA accreditation for its Edmonton clinic, with Calgary accreditation in progress.

Adjacent to clinical services, ATMA CENA operates a professional training business delivered via the Kajabi learning platform. The catalog comprises three CE/CME-accredited pathways (Clinical, Prescriber, Integrative) plus add-on modules including PAT Foundations, Applied Clinical Practice, Supervised Learning Lab, and KAT Immersive Experience, with per-course tuition ranging from $800 to $4,200 CAD. Over 1,000 practitioners have been trained since 2021. Trained clinicians can join the CoCare program to deliver PAT within ATMA CENA's national network.

The third revenue engine is a member clinic network that currently comprises 11 partner clinics across Ontario, Quebec, Saskatchewan, and Manitoba, structured with exclusive per-city market positioning. Member clinics pay for protocols, staff training, regulatory guidance, and operational systems under a franchise-like arrangement, while ATMA CENA earns licensing/membership fees and routes patient referrals through its physician and therapist referral programs. The company is privately held, was formed in 2023 as a joint venture between Cena Life and ATMA Journey, employs 11-50 staff, and is actively soliciting investors through a Psychedelic Therapy Investor Program with a stated goal of doubling annual revenue each year for the next three years.

Name

ATMA CENA

Legal name

AtmaCena Inc.

Website

https://atmacena.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

ATMA CENA operates a Canadian specialty mental healthcare platform delivering psychedelic-assisted therapy, rTMS, and general therapy through two corporate clinics in Alberta and an 11-clinic national member network, while running CE/CME-accredited professional training programs and an investor-backed growth program.

Ownership category

akta.pro rank

Product category

Mental Healthcare / Psychedelic-Assisted Therapy Services

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420), Outpatient Mental Health and Substance Abuse Centers (62142), Educational Support Services (61171)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Behavioral Health & Counseling (Social Work, Psychology, Substance Use CE) (EDAAALAD)

akta.pro secondary industry

Controlled-Substance & High-Risk Medication Teleprescribing Platforms (compliance-focused) (HLALAIAM)

Keywords

• Psychedelic-assisted therapy
• Transcranial magnetic stimulation
• Mental health treatment
• Professional therapy training
• Clinic network membership

Headquarters

HQ city

Calgary

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Clinical Therapy Services: Direct patient care including psychedelic-assisted therapy (ketamine, psilocybin, MDMA through SAP), rTMS, and general therapy services. Revenue generated from treatment sessions at corporate clinics in Edmonton and Calgary and through member clinic network.
2. Professional Training Programs: CE-sponsored psychedelic therapy training programs across three pathways (Clinical, Prescriber, Integrative). Revenue from course tuition including PAT Foundations, Applied Clinical Practice, Prescribing & Oversight, Advanced Safety & Support Practices, Supervised Learning Lab, and KAT Immersive Experience.
3. Member Clinic Network: National clinic network membership providing regulatory guidance, staff training, operational systems, and access to qualified therapist referral network. Partner clinics receive exclusive market positioning in their communities.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

ATMA CENA operates a network of licensed clinics providing psychedelic-assisted therapy (using ketamine, psilocybin, and MDMA through the SAP), repetitive transcranial magnetic stimulation (rTMS), and general therapy services for treatment-resistant mental health conditions. The company complements its clinical practice with three CE/CME-accredited professional training pathways and a CoCare model that lets graduates deliver PAT within ATMA CENA-affiliated clinics, as well as a National Member Clinic Network that franchises ATMA CENA protocols and brand across Canada with one clinic per city.

Product overview

ATMA CENA operates a platform-plus-network model for psychedelic-assisted mental healthcare. The core offering comprises three main service lines: General Therapy Services, Psychedelic-Assisted Therapy (PAT) using ketamine, and Repetitive Transcranial Magnetic Stimulation (rTMS). PAT serves as the flagship innovative treatment for treatment-resistant conditions. Adjacent to clinical services, ATMA CENA offers professional training through three pathways (Clinical, Prescriber, Integrative) plus optional Supervised Learning Lab and KAT Immersive Experience, all delivered via Kajabi. The CoCare Program allows trained practitioners to practice within ATMA CENA's network. A National Clinic Network Member Program extends the brand nationally through franchised member clinics. Supporting infrastructure includes Physician/NP and Therapist referral programs. The company also maintains an investor relations program for capital raising.

Differentiator

Problem solved

Functional benefit

Brands

• CoCare: A program enabling clinic owners and practitioners to integrate psychedelic-assisted therapy into their practices with ATMA CENA's clinical protocols, operational systems, and access to a therapist referral network.
• Psychedelic Therapy Training

Products and services

• General Therapy Services Traditional therapy services provided by licensed therapists for individuals and families addressing various mental health concerns and life challenges, delivered at ATMA CENA's Edmonton and Calgary corporate clinics.
• Psychedelic-Assisted Therapy (PAT) Innovative mental health treatment combining psychedelic medicine administration (ketamine, psilocybin, and MDMA through SAP) with professional psychological support to achieve therapeutic outcomes for depression, PTSD, anxiety, and addiction, delivered at licensed Alberta corporate clinics.
• Repetitive Transcranial Magnetic Stimulation (rTMS) Non-invasive brain stimulation therapy using magnetic fields to stimulate nerve cells in the brain for treatment of depression and other mental health conditions, characterized by minimal side effects, delivered at ATMA CENA's Edmonton and Calgary clinics.
• Psychedelic Therapy Training — Clinical Pathway Professional training program for licensed therapists, psychologists, counselors, and social workers preparing to deliver psychedelic-assisted therapy directly, including supervised practice pathways and CE credits (anchored by the Applied Clinical Practice 46-hour course at CAD $4,200).
• Psychedelic Therapy Training — Prescriber Pathway Training program for physicians, psychiatrists, and nurse practitioners covering prescribing authority, medical oversight, and clinical protocols for psychedelic-assisted therapy, eligible for CME credits.
• Psychedelic Therapy Training — Integrative Pathway Training pathway for wellness professionals including coaches, addictions counselors, and allied health practitioners entering the field of psychedelic-assisted therapy within collaborative care models.
• PAT Foundations 14-hour self-paced online foundational course covering history, science, ethics, and clinical application of psychedelic-assisted therapy, earning 14 CE credits upon completion.
• Supervised Learning Lab Small-group live skills practice session (four weekly two-hour live sessions capped at eight participants) for hands-on training in psychedelic-assisted therapy techniques.
• KAT Immersive Experience Optional 3-day in-person experiential training where practitioners experience the full arc of ketamine-assisted therapy from the client perspective, including intake, preparation, supervised dosing weekend, and integration in groups of up to 10 participants.
• CoCare Program Program enabling qualified therapists and practitioners to offer psychedelic-assisted therapy in their own practices with ATMA CENA providing clinical protocols, operational systems, and access to the clinic network.
• National Clinic Network Member Program Franchise-like network partnership allowing clinic owners to integrate psychedelic-assisted therapy services with ATMA CENA providing regulatory guidance, staff training, clinical protocols, and exclusive market positioning per city.

Quantifiable outcome

• Over 1,000 practitioners trained since 2021
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature3 records

Partnerships

Five partnerships are on record, tiered core.

• MAPS CanadacoreStrategic or Co-development Partner · 1 October 2025Co-authored position paper on Alberta's Psychedelic Drug Treatment Services framework with MAPS Canada. Reverdi Darda, CEO, co-authored the report providing balanced analysis of provincial regulations. Joint advocacy for safety and access in psychedelic regulation.
• The Rooted SpacecoreChannel Partner/ Reseller/ DistributorMember clinic partner in Kitchener-Waterloo, Ontario. Integrative wellness clinic offering psychedelic-assisted psychotherapy, traditional psychotherapy, neurofeedback, and holistic wellness services. Empowered by ATMA CENA to offer PAT services.
• NeuroMedcoreChannel Partner/ Reseller/ DistributorMember clinic partner in Winnipeg providing psychedelic-assisted therapy services as part of ATMA CENA's national clinic network.
• Evolve Counselling and WellnesscoreChannel Partner/ Reseller/ DistributorMember clinic partner in Saskatoon offering psychedelic-assisted therapy as part of the ATMA CENA national clinic network.
• College of Physicians and Surgeons of Alberta (CPSA)coreStrategic or Co-development PartnerRegulatory oversight body that provides accreditation for ATMA CENA's Edmonton clinic and oversees the accreditation process for Calgary clinic. Sets standards for psychedelic-assisted therapy in Alberta under PDTS framework.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Braxia Scientific: Canadian ketamine clinic operator and psychiatric research platform (now part of Numinus). Directly comparable to ATMA CENA on ketamine-assisted therapy delivery and Canadian specialty outpatient mental-health positioning.
• Field Trip Health: Was a leading Canadian psychedelic therapy clinic operator (ketamine-assisted psychotherapy) with locations across North America before ceasing operations. Served as the prior template for ATMA CENA's clinic-plus-network model in the Canadian market.
• Numinus Wellness: Canadian psychedelic therapy company operating clinics and offering ketamine-assisted therapy alongside practitioner training. Numinus is the closest geographic and business-model peer to ATMA CENA, including its acquisition of Braxia Scientific (Canadian ketamine clinics).
• Novamind: Operates specialty mental-health and ketamine-assisted therapy clinics in Canada alongside clinical research sites. Comparable to ATMA CENA in combining outpatient psychedelic therapy delivery with research capabilities.
• Wesana Health: Focused on psychedelic-assisted therapies for traumatic brain injury and neurological conditions. Comparable niche overlap with ATMA CENA's chronic pain and tinnitus psychedelic treatment indications.

Emerging players

• Cybin: Clinical-stage psychedelic therapeutics company developing psilocybin-based treatments for mental health. Comparable to ATMA CENA's psilocybin-assisted therapy segment but at the drug-development phase.
• MAPS Public Benefit Corporation: Subsidiary of MAPS focused on developing and delivering MDMA-assisted therapy. Strongly comparable to ATMA CENA's MDMA-via-SAP offering and a key advocacy partner shaping psychedelic therapy policy that ATMA CENA is engaging.
• GH Research: Clinical-stage company developing mebufotenin (5-MeO-DMT)-based therapies for treatment-resistant depression. Adjacent to ATMA CENA's psychedelic therapy menu, focused on a different molecule but a similar treatment-resistant mental-health patient population.

Broad incumbents

• Compass Pathways: Public clinical-stage company developing psilocybin therapy for treatment-resistant depression. Overlaps with ATMA CENA on psilocybin-assisted therapy but operates as a drug-development incumbent rather than a clinic operator.
• MindMed: Public psychedelic medicine company developing LSD and MDMA-based therapies. Comparable to ATMA CENA's PAT offering but at the biopharma development stage rather than clinic-delivery stage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/atmacenaphs
• LinkedInlinkedin.com/company/atma-cena
• Instagraminstagram.com/atmacena
• Xx.com/atmacena_x

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ATMA CENA